...
首页> 外文期刊>Oncoimmunology. >Antibody response to cancer/testis (CT) antigens: A prognostic marker in cancer patients
【24h】

Antibody response to cancer/testis (CT) antigens: A prognostic marker in cancer patients

机译:对癌症/睾丸(CT)抗原的抗体反应:癌症患者的预后标志物

获取原文
获取原文并翻译 | 示例
           

摘要

Immune responses to tumor antigens have been reported in cancer patients. However, the relevance of such spontaneous immune responses to the clinical course has not been studied extensively. We showed that the overall survival of patients with antibodies against NY-ESO-1 or XAGE1 (GAGED2a) antigen was prolonged in gastric or lung cancer patients, respectively.
机译:在癌症患者中已经报道了对肿瘤抗原的免疫反应。然而,尚未对这类自发性免疫反应与临床过程的相关性进行广泛研究。我们显示,在胃癌或肺癌患者中,分别使用抗NY-ESO-1或XAGE1(GAGED2a)抗原的抗体的患者的总生存期得以延长。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号